Market Overview

Benzinga's Top Downgrades

Share:
Benzinga's Top Downgrades
Related CVS
The Customer Is Always Right: This ETF Is Tailored To Customer Satisfaction
Partisan Politics May Be To Blame For Hold Up In Walgreens-Rite Aid Deal
GNC: Updated Short Interest And Goldman Sachs' $5 Price Target (Seeking Alpha)
Related RM
18 Biggest Mid-Day Losers For Friday
Benzinga's Top Downgrades

Analysts at Cantor Fitzgerald downgraded CVS (NYSE: CVS) from “buy” to “hold.” The target price for CVS has been lowered from $65 to $62. CVS's shares closed at $59.89 yesterday.

Jefferies downgraded Regional Management (NYSE: RM) from “buy” to “hold.” The target price for Regional Management is set to $29. Regional Management's shares closed at $31.20 yesterday.

Bank of America downgraded Marathon Oil (NYSE: MRO) from “buy” to “neutral.” The target price for Marathon Oil has been lowered from $45 to $42. Marathon Oil's shares closed at $36.88 yesterday.

Analysts at McNicoll Lewis Vlak downgraded ACADIA Pharmaceuticals (NASDAQ: ACAD) from “buy” to “hold.” The target price for ACADIA Pharmaceuticals has been raised from $18 to $20. ACADIA's shares closed at $20.68 yesterday.

Latest Ratings for CVS

DateFirmActionFromTo
Feb 2017BairdDowngradesOutperformNeutral
Dec 2016JefferiesAssumesBuyHold
Oct 2016UBSInitiates Coverage onBuy

View More Analyst Ratings for CVS
View the Latest Analyst Ratings

Posted-In: Top DowngradesDowngrades Analyst Ratings

 

Related Articles (ACAD + CVS)

View Comments and Join the Discussion!